Hospira Recalls Dacarbazine Injection Vials Due to Discoloration
Hospira Inc. is recalling 3,306 vials of Dacarbazine Injection, USP, 200mg, because the reconstituted solution may appear pink instead of the expected colorless to pale yellow.
- Product
- Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.
- Category
- Drug
- Distribution
- Distributed nationwide